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Abstract 
 
Allodynia has been described in migraine but has not been fully investigated for 
the different sensory modalities. The aim of this study was to compare the prev-
alence of dynamic (brush) and static (pressure) mechanical allodynia in migraine 
patients and to suggest a practical method of testing them in a clinical setting. 
Patients with International Headache Society-defined episodic migraine (EM) or 
with transformed migraine (TM) as defined by Silberstein and Lipton were pro-
spectively recruited from the Jefferson Headache Center out-patient clinic. A 
questionnaire of migraine features and symptoms of allodynia was 
administered. Brush allodynia (BA) was tested by cutaneous stimulation with a 
  
gauze pad and pressure allodynia (PA) was tested using von Frey hairs (VFH). 
The prevalence of BA and PA in all patients and in the different subgroups was 
calculated and correlated with migraine features. We recruited 55 migraine 
patients. Twenty-five had EM and 30 had TM. BA was present in 18 (32.7%) 
patients and PA in 18–24 (32.7–43.6%). Allodynia to both brush and pressure 
was found in 13–17 (23.6– 30.9%) patients. If a patient had allodynia to one 
modality only, it was more likely to be PA than BA. Both BA and PA were more 
common in patients with TM compared with those with EM [BA 46.7% vs. 
16.0%; PA (differences significant for the medium and thick VFHs) 50% vs. 
20% and 50% vs. 12%, respectively]. Both types of allodynia were also more 
common in patients with migraine with aura compared with those with migraine 
without aura (BA 57.1% vs. 17.6%; PA 57.1– 61.9% vs. 17.6–32.7%). There 
was a positive correlation between allodynia score (as obtained by 
examination) and allodynia index (as obtained by history) for both BA and PA. 
The incomplete, although considerable, overlap between BA and PA suggests that 
allodynia to different sensory modalities is associated with sensitization of 
different neuronal populations. Because PA was more common than BA, it may 
be a more sensitive indicator of allodynia in migraine. PA can be tested clinically 
in a practical and systematic manner.  
 
Introduction 
Allodynia is a phenomenon in which normally non-painful stimuli are perceived as 
painful. Cutaneous allodynia is present in approximately 80% of migraine 
  
 
 
patients during an acute attack (1). There are four types of cutaneous allodynia: 
(i) dynamic mechanical (brush), (ii) static mechanical (pressure), (iii) heat and 
(iv) cold. Allodynia in migraine has not been fully investigated for the different 
sensory modalities. Burstein et al. investigated heat, cold and static, but not 
dynamic, mechanical allodynia (1, 2). There is evidence that allodynia in migraine 
is associated with a poor response to triptans (3). Therefore, identifying and 
using the optimal method to test migraine patients for allodynia is of clinical 
value. In this study, we compared the prevalence of brush and pressure allodynia 
in migraine patients. We also propose a systematic and practical method to test 
patients for allodynia and suggest the use of a brief questionnaire to determine 
the presence of allodynia in migraine patients. 
Methods 
This study was approved by the Institutional Review Board for Studies with 
Human Subjects of Jefferson University Hospital. All patients signed a document 
of informed consent prior to enrolment in the study. 
Patients with International Headache Society (HIS)-defined episodic 
migraine (EM) or transformed migraine (TM) as defined by Silberstein and Lipton 
were prospectively recruited from the Jefferson Headache Center out-patient 
clinic (4–6). Briefly, the criteria for TM were: (i) headache for >15 days/ month 
for >1 month; (ii) average headache duration of >4 h/day (untreated); (iii) at 
least one of the following: (a) history of IHS-defined episodic migraine, (b) 
history of increasing headache frequency with decreasing severity, (c) current 
headache meets IHS criteria for migraine other than duration; (iv) exclusion of 
  
secondary causes of headache (5). Control subjects were recruited to determine 
cut-off values for pressure allodynia. These were spouses and relatives of 
patients, recruited from the clinic’s waiting room, who did not suffer from 
migraine headaches. Exclusion criteria for both groups were the presence of 
peripheral neuropathy or other neurological diseases that may affect sensory 
function, dermatological disease that may affect skin sensation, secondary 
headaches (e.g. headache resulting from Lyme disease, post-traumatic 
headache) or a diagnosis of new daily persistent headache. Patients were 
allowed to be on headache-preventive medications while participating in the 
study. A questionnaire of demographic data, migraine history, migraine attack 
features and symptoms of allodynia was administered. A seven-point allodynia 
index was determined by the results of the questionnaire (Table 1).   
     Migraine patients were tested for both static mechanical (pressure) and 
dynamic mechanical (brush) cutaneous allodynia. Brush allodynia (BA) was 
tested by gently applying a folded 4 × 4-in gauze pad to the skin, 10 times at 
a frequency of 2/s as we previously described (7). Pressure allodynia (PA) was 
tested by applying von Frey hairs (VFH) (Touch-TestTM Sensory Evaluators; 
North Coast Medical, Inc. Morgan Hill, CA, USA) of three different weights, 1.4 
g, 8 g and 60 g, three times to each area, holding down for 1 s and releasing. 
Since there are no standardized measures for the amount of pressure that 
causes pain in normal subjects, the selection of these weights was somewhat 
arbitrary. The skin areas tested for both BA and PA were the forehead (V1), 
posterior neck (C2, C3) and inner forearm (C8), bilaterally. The degree of pain 
  
 
 
or unpleasant sensation upon stimulation was measured using a 100-mm visual 
analogue scale (VAS). 
A potential confounder in the comparison of the two modalities is the 
subjective distinction between pressure and pain. While any pain sensation 
resulting from light cutaneous stimulation with a gauze pad is defined as 
allodynia, some patients may have difficulty in the distinction between a sensation 
of pressure and pain. To define PA, we used the control group. A number of 
control subjects did report pain in response to VFH application. To classify a 
subject’s response as allodynic in a standardized manner, the cut-off value for 
allodynia was defined as the pain level on the VAS below which 95% of control 
subjects responded. These cut-off values were 5 mm, 34 mm and 43 mm for the 
1.4-g, 8-g and 60-g VFHs, respectively. 
An allodynia score was determined as the sum of allodynia levels as 
determined by VAS at the different sites. This score was correlated with head 
pain level at the time of testing. The prevalence of BA and PA was determined 
for all the patients, as well as for each group (EM and TM) separately. 
Data were analysed for the following subgroups: patients with and without 
BA, patients with or without PA to thin, medium or thick VFHs. Fischer’s 
exact test was used to compare the frequencies of categorical variables such as 
diagnosis. Wilcoxon scores were used to compare disease duration within these 
subgroups. Pearson correlation coefficients were calculated to determine 
correlations between allodynia scores and allodynia indices, as well as head pain 
severity. 
  
Results 
We recruited 55 migraine patients (43 women, 12 men, mean age 42.9 ± 14.4 
years) and 21 non-migraine control subjects (13 women, eight men, mean age 
43.6 ± 16.4 years). Twenty-five patients had EM and 30 had TM. Average 
disease duration in the entire study population was 21 years, with no significant 
difference between patients with EM and those with TM (possibly due to a 
selection bias of episodic migraine patients who attend a tertiary headache 
clinic). Average frequency of acute attacks was 2.3/month in the EM group 
and 4.6/month in the TM group. Seven patients were tested during an acute 
migraine attack. Six of these patients had allodynia, with five having both BA and 
PA and one having only PA. The mean time interval between attack onset and 
allodynia testing was 23 h (range 2– 72 h). Of those patients who were tested 
during an acute attack, two had taken acute migraine drugs less than 2 h prior 
to testing [one took dihydroergotamine (DHE) and one took zolmitriptan]. The 
patient who had taken DHE had PA only, while the patient who had taken 
zolmitriptan experienced allodynia to both modalities. 
Overall, the prevalence of PA was higher than that of BA. BA was present 
in 18 (32.7%) patients and PA in 18–24 (32.7–43.6%), depending on the 
weight of the VFH applied (Fig. 1). If a patient had allodynia to one modality 
only, it was more likely to be PA than BA (Fig. 2a–c). Both BA and PA were more 
common in TM compared with EM [BA 46.7% vs. 16.0%, P = 0.02; PA 
(differences significant for the medium and thick VFHs) 50% vs. 20%, P = 0.03 
and 50% vs. 12%, P = 0.004, respectively] (Fig. 3). Both types of allodynia were 
  
 
 
also more common in patients with migraine with aura (MA) compared with those 
with migraine without aura (MoA) [BA 57.1% vs. 17.6%, P = 0.003; PA (data 
shown for thin hairs) 61.9% vs. 32.7%, P = 0.3] (Fig. 4). 
There was a positive correlation between allodynia score (obtained by 
examination) and allodynia index (obtained by history) for both BA (0.39, 
P = 0.003) and PA (0.39–0.40, P < 0.003) (Table 2). There was also a positive 
correlation between allodynia score and headache level at time of testing for 
both BA (0.56, P < 0.001) and PA (0.43–0.50, P < 0.0007) (Table 2). We 
found no statistically significant correlation between disease duration and the 
score of either BA or PA. 
Discussion 
Using cut-offs based on a control population of non-migraine subjects, we were 
able to differentiate between migraine patients with and without PA. The 
use of VFHs may be useful to detect PA in migraine patients in a clinical setting. 
Triptan therapy for migraine has little efficacy once allodynia has occurred (3). 
Therefore, having a practical tool to assess this phenomenon will aid in 
choosing treatment. 
Allodynia is thought to arise from central sensitization of second- and 
third-order neurons in the trigeminal nucleus caudalis (TNC) or thalamus (1). 
Nociceptive input from dural vessels during a migraine attack may activate the 
secretion of inflammatory intermediates and neurotransmitters that promote 
neuronal hyperexcitability. Central sensitization is associated with activation of 
glutamate and substance P receptors (8, 9). These can then activate secondary 
  
messengers such as protein kinase C and protein kinase A (8). The pattern of 
allodynia would therefore correspond to higher order representations of sensory 
input. 
PA was more prevalent than BA in this migraine patient group. This 
indicates that PA may be a more sensitive measure of central sensitization during 
migraine than BA. There was a considerable, but not complete, overlap between 
the PA and BA groups, regardless of the weight of VFH used. This suggests that 
PA and BA in migraine result from central sensitization of similar, but not 
identical, neuronal populations. It also suggests that there are separate 
pathways through which sensitization to brush and to pressure stimuli occur. 
Both PA and BA were more common in patients with TM than in those with 
EM. In a previous study, we demonstrated a high prevalence of BA in TM both 
during baseline headaches and during headache exacerbations (10). The 
prevalence of BA in EM in that study was lower than that of TM, but increased 
significantly when EM patients were tested during an acute attack. The findings 
of the current study are consistent with these results and suggest that migraine 
patients with little or no headache are unlikely to have allodynia. 
The higher prevalence of allodynia in patients with TM suggests that 
allodynia may result from a process of repeated neuronal sensitization in the 
TNC over time. It is of interest to note that similar results were found in 
cluster headache (CH) patients: the prevalence of BA in these patients was 
higher in chronic, compared with episodic CH, further supporting the above 
notion (11). In this study, however, we found no significant difference in disease 
  
 
 
duration between patients with allodynia and those without allodynia. This may 
be due to the small number of patients. 
Both BA and PA were more common in MA compared with MoA in this 
study. There is no satisfactory explanation to this interesting finding. It suggests, 
however, that in patients with MA there is a lower threshold for neuronal 
sensitization in the TNC compared with that of patients with MoA. This hypothesis 
needs further study. 
Finally, our study demonstrates that self-reporting of allodynic symptoms 
correlates with the presence of allodynia upon testing. This confirms the useful-
ness of the seven-point questionnaire in rapidly assessing the presence of 
allodynia in the clinic. 
Patients in this study were allowed to remain on migraine-preventive 
drugs. This may have had an effect on our results since some migraine-
preventive drugs (e.g. gabapentin) have been shown to reduce allodynia (12). 
The use of acute migraine drugs was also allowed in the study, but only two 
patients had used them less than 2 h prior to allodynia testing. Sumatriptan has 
been shown to cause transient allodynia in migraine patients, but this effect was 
short lasting (<40 min) (13). The effect of acute migraine drugs on the results of 
allodynia testing in this studyis therefore not likely to be significant. Another 
limitation of this study is that patients with EM and those with TM were not 
analysed separately. Although data on the occurrence of cutaneous allodynia in 
TM are sparse, patients with TM and those with EM may differ as regards central 
sensitization and the occurrence of cutaneous allodynia. Further studies are 
  
needed to examine the value of PA measurement in migraine, to analyse its 
occurrence in EM and in TM separately and to correlate it with treatment 
outcome. 
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TABLES & FIGURES 
 
Table 1 A questionnaire to assess symptoms of allodynia. Allodynia index is 
the sum of positive answers 
_____________________________________________________________ 
Is your headache made worse by: 
 Tilting or bending down your head  ( ) yes; ( ) no 
 Coughing       ( ) yes; ( ) no 
 Climbing stairs      ( ) yes; ( ) no 
Do any of the following bother you when you have a headache: 
 Touching your scalp or face    ( ) yes; ( ) no 
 Wearing any object on your head/neck  ( ) yes; ( ) no 
     (hat, jewelry, glasses, necklaces, etc.) 
 Wearing any object on your arms/wrist  ( ) yes; ( ) no 
     (watch, jewelry, long sleeves, etc.) 
 Exposure of your face/head to wind  ( ) yes; ( ) no 
_________________________________________________________________ 
 
 
  
 
 
Table 2 Correlation between allodynia index (obtained by questionnaire) and 
allodynia scores (obtained by examination) and between headache level at time 
of testing and allodynia scores 
Parameter Modality of allodynia score 
Pearson 
correlation 
coefficient P-value
Allodynia index Brush allodynia 0.39 0.0030
 Pressure allodynia (thin hair) 0.39 0.0031
 Pressure allodynia (medium hair) 0.40 0.0024
 Pressure allodynia (thick hair) 0.39 0.0030
Headache level at  Brush allodynia 0.56 <0.0001
time of testing Pressure allodynia (thin hair) 0.43 0.0011
 Pressure allodynia (medium hair) 0.50 <0.0001
 Pressure allodynia (thick hair) 0.43 0.0007
 
 
  
Figure 1  Prevalence of brush allodynia (BA) and of pressure allodynia (PA) with 
thin (1.4 g), medium (8 g) and thick (60 g) von Frey hairs (VFHs).   
 
 
 
 
 
 
 
 
 
 
Figure 2  The overlap of brush allodynia (BA) and pressure allodynia (PA) 
using thin (a), medium (b) and thick von Frey hairs (c) 
  
 
 
 
 
  
 
Figure 3  Prevalence of brush allodynia (BA) and pressure allodynia (PA) in 
patients with transformed migraine (□) and episodic migraine ( ). 
 
 
Figure 4 Prevalence of brush allodynia (BA) and pressure allodynia (PA) (for 
thin von Frey hairs) in patients with migraine with aura (□, n = 21) and in those 
with migraine without aura ( , n = 34). 
 
